AGEN(Agenus Inc.) · 财务报表

AGEN(Agenus Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$295.67M$98.02M$156.31M$103.46M$114.20M
毛利润$292.19M$87.46M$153.20M$102.98M$113.17M
营业利润$25.75M−$179.43M−$159.55M−$120.47M−$20.17M
净利润−$28.72M−$230.66M−$257.44M−$232.27M−$3.08M
经营现金流$10.14M−$175.37M−$224.20M−$158.31M−$77.19M
自由现金流−$23.67M−$228.44M−$234.16M−$158.89M−$77.20M
摊薄每股收益$-2.20$-15.64$-13.75$-10.59$0.00

Agenus Inc. AGEN